Mood Stabilizers

On this page

Overview & Lithium - The OG Mood Tamer

  • Mood Stabilizers: Prevent/treat mood episodes (mania/depression) in Bipolar Disorder (BPD) without switching poles. Also: schizoaffective disorder.
    • Types: Lithium, Anticonvulsants (Valproate, Lamotrigine), Atyp. Antipsychotics.
  • Lithium (Li+):
    • MOA: ↓ IP3/DAG, ↓ GSK-3β.
    • Uses: Acute mania, BPD prophylaxis, anti-suicidal.
    • PK: Oral, renal excretion (competes with Na+).
    • Range: Therapeutic 0.6-1.2 mEq/L. Toxic > 1.5 mEq/L. Severe > 2.5 mEq/L.
    • Side Effects:
      • GI (N/V/D), fine tremor (Rx: propranolol).
      • Renal: Polyuria/polydipsia (Nephrogenic Diabetes Insipidus - NDI).
      • Thyroid: Hypothyroidism, goiter.
      • Cardiac: T-wave changes.
      • Teratogenic: Ebstein's anomaly (📌 Lithium → Low Ebstein's).
    • Monitor: Li levels, RFT, TFT.
    • ↑ Li: Thiazides, NSAIDs, ACE-I.

⭐ Lithium is unique for its anti-suicidal properties in BPD and can cause Nephrogenic Diabetes Insipidus (NDI) and hypothyroidism.

Valproate & Lamotrigine - Seizure Stoppers, Mood Menders

Valproate (VPA):

  • Primary for: Acute mania, mixed states, prophylaxis.
  • MOA: ↑GABA effects, blocks Na+/Ca++ channels.
  • Key SE: Weight gain, tremor, alopecia, hepatotoxicity, pancreatitis.
  • ⚠️ Teratogenic (Neural Tube Defects). 📌 VPA: Very Problematic during All trimesters (pregnancy).
  • Monitoring: LFTs, CBC. Therapeutic range: 50-125 µg/mL.

Lamotrigine (LTG):

  • Primary for: Bipolar depression, maintenance therapy.
  • MOA: Blocks Na+ channels, ↓glutamate release.
  • Key SE: Rash (potential for SJS/TEN!), headache. 📌 LTG: Look for Threatening Generalized rash.
  • ⚠️ Slow titration crucial to prevent Stevens-Johnson Syndrome (SJS).

Comparison: VPA vs. LTG

FeatureValproate (VPA)Lamotrigine (LTG)
Bipolar PhaseMania, MixedDepression, Maintenance
Key SE RiskHepatotoxicity, NTDs, PancreatitisStevens-Johnson Syndrome (SJS)
TitrationStandardSlow, cautious
Loading diagram…

⭐ Valproate: High risk of Neural Tube Defects. Lamotrigine: Key for bipolar depression; ⚠️ slow titration prevents SJS.

Carbamazepine & Atypicals - The Backup Crew

Carbamazepine (CBZ):

  • Uses: Bipolar (mania, maintenance), trigeminal neuralgia, seizures.
  • MOA: Na+ channel blocker.
  • Side Effects:
    • CNS: Drowsiness, ataxia.
    • Hematologic: Agranulocytosis, aplastic anemia (monitor CBC).
    • SIADH (hyponatremia).
    • Rash, SJS/TEN (screen HLA-B*1502 in Asians).
  • Kinetics: Autoinducer (3-5 weeks); CYP450 inducer (↓ other drugs).
  • Related: Oxcarbazepine - less enzyme induction, ↓rash/hematotoxicity risk.

Atypical Antipsychotics as Mood Stabilizers:

  • Role: Acute mania, bipolar depression, maintenance.
DrugPrimary Indication (Mood)Key Metabolic Side Effect(s)
OlanzapineAcute mania, maintenance↑ Weight, dyslipidemia
RisperidoneAcute mania, mixed episodes↑ Weight, hyperprolactinemia
QuetiapineMania, bipolar depression, maint.↑ Weight, sedation
AripiprazoleAcute mania, maintenanceAkathisia, less weight gain

​

Clinical Use & Special Populations - Mood Navigator

Loading diagram…
  • General Principles:
    • Acute Mania: Lithium, Valproate, AAPs. ECT for severe cases.
    • Bipolar Depression: Lamotrigine, Quetiapine, Lurasidone. Avoid antidepressant monotherapy.
    • Maintenance: Lithium, Lamotrigine, Valproate, LAI AAPs.
  • Special Populations:
    • Pregnancy:

      ⭐ Lithium: Ebstein's anomaly risk (1st trimester), monitor levels. Valproate: ⚠️ High teratogenicity (NTDs, ↓IQ) - CONTRAINDICATED. Lamotrigine: Relatively safer, cleft risk, monitor levels (may ↓).

      • Carbamazepine: NTDs. Avoid.
    • Renal Impairment: Lithium (↓ dose, monitor closely, or avoid). Valproate/Lamotrigine preferred.
    • Hepatic Impairment: Valproate (⚠️ AVOID - hepatotoxicity). Lamotrigine/Lithium preferred.
    • Elderly: "Start low, go slow." ↑Sensitivity. Lithium (↑neuro/nephrotoxicity), Valproate (sedation, ataxia).

High‑Yield Points - ⚡ Biggest Takeaways

  • Lithium: Gold standard for bipolar disorder. Narrow therapeutic index; monitor renal/thyroid, levels. Risk: Ebstein's anomaly.
  • Valproate: For acute mania, rapid cycling. Risks: neural tube defects, hepatotoxicity, pancreatitis.
  • Carbamazepine: Risks: agranulocytosis, SIADH. Potent enzyme inducer (autoinduction).
  • Lamotrigine: For bipolar depression. Slow titration prevents Stevens-Johnson Syndrome (SJS).
  • Atypical antipsychotics (e.g., olanzapine, quetiapine) also used as mood stabilizers, especially in acute mania.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Mood Stabilizers

  1. 1. Which drug is used to treat symptomatic bradycardia and excessive secretions in nicotine poisoning?

    • A. Atropine
    • B. Phentolamine
    • C. Neostigmine
    • D. Trimethaphan
    Show answer

    Answer: A. Atropine

    Atropine - Atropine competitively antagonizes muscarinic acetylcholine receptors, relieving cholinergic manifestations such as bradycardia, excessive salivation, bronchorrhea, and bronchospasm in severe nicotine poisoning. - Nicotine produces a biphasic autonomic toxidrome through initial stimulation followed by paralysis; although overall treatment requires supportive care, atropine provides targeted relief of prominent muscarinic effects. Phentolamine - Phentolamine is an alpha-adrenergic blocker used mainly for catecholamine-mediated hypertension and does not treat the primary muscarinic or nicotinic toxicity of nicotine poisoning. - Although nicotine may initially cause sympathetic stimulation, phentolamine is not the appropriate treatment for the prominent cholinergic manifestations of severe poisoning. Neostigmine - Neostigmine inhibits acetylcholinesterase, increasing acetylcholine concentrations at synapses and neuromuscular junctions. - Because nicotine poisoning already causes excessive cholinergic stimulation, neostigmine could worsen muscarinic effects rather than provide therapeutic relief. Trimethaphan - Trimethaphan is a nonselective ganglionic blocker acting at nicotinic receptors, so it does not specifically reverse the muscarinic manifestations of nicotine toxicity. - Its obsolete use and risk of severe hypotension make it unsuitable; supportive care and targeted atropine therapy are preferred.

  2. 2. A 30-year-old man treated with imipramine for depression for 2 weeks develops increased excitement, excessive talking and conspicuously colorful dressing. What is the next step in management?

    • A. Imipramine+valproate
    • B. Sertraline alone
    • C. Valproate alone
    • D. Imipramine+olanzapine
    Show answer

    Answer: C. Valproate alone

    Valproate alone is the best listed regimen because the new excitement and excessive talking suggest an antidepressant-associated manic switch, requiring discontinuation of imipramine. Imipramine+valproate retains the potentially precipitating antidepressant. Sertraline alone would continue antidepressant treatment during the manic switch rather than provide antimanic treatment. Imipramine+olanzapine includes an antimanic drug but unnecessarily continues imipramine.

  3. 3. An adult with non-withdrawal delirium remains dangerously agitated despite de-escalation. QTc is normal, and there is no Parkinson disease or Lewy body dementia. Which drug is appropriate for short-term symptom control?

    • A. Valium
    • B. Dormicum
    • C. Haldol
    • D. Ativan
    Show answer

    Answer: C. Haldol

    Haldol is appropriate for short-term control of dangerous agitation in non-withdrawal delirium after de-escalation fails and relevant contraindications are absent. Ativan, Valium and Dormicum are benzodiazepines that can worsen non-withdrawal delirium and are not routine choices for this indication; benzodiazepines have a different role in alcohol or sedative withdrawal.

  4. 4. According to DSM-IV criteria, what is the minimum duration of depressed mood or loss of interest or pleasure required for the diagnosis of a Major Depressive Episode?

    • A. 4 weeks
    • B. 3 weeks
    • C. 2 weeks
    • D. 1 week
    Show answer

    Answer: C. 2 weeks

    2 weeks - Two weeks is the DSM-IV minimum duration for depressed mood or anhedonia, occurring nearly every day as part of the required symptom cluster. - This 14-day threshold helps distinguish persistent clinical depression from transient sadness or ordinary mood fluctuations. 1 week - One week is insufficient for a Major Depressive Episode, which requires symptoms nearly every day for at least 14 consecutive days. - A one-week duration is classically associated with the minimum duration for a manic episode, not a depressive episode. 4 weeks - Four weeks exceeds the minimum DSM-IV duration and is therefore not the required threshold for diagnosing a Major Depressive Episode. - Requiring four weeks could delay recognition of clinically significant depression; the diagnostic threshold is two weeks with sufficient symptoms. 3 weeks - Three weeks has no specific diagnostic significance for the minimum duration of a Major Depressive Episode in DSM-IV. - Although symptoms may persist for three weeks or longer, the diagnosis can be made after the required two-week duration if other criteria are met.

  5. 5. Which of the following antipsychotics has the highest risk of extrapyramidal adverse effects at usual therapeutic doses?

    • A. Quetiapine fumarate
    • B. Haloperidol
    • C. Olanzapine
    • D. Clozapine
    Show answer

    Answer: B. Haloperidol

    Haloperidol has the highest risk of extrapyramidal adverse effects among these options at usual therapeutic doses because of potent nigrostriatal D2 receptor blockade; the alternatives have lower, not absent, risk. Quetiapine fumarate - Quetiapine fumarate is an atypical antipsychotic with relatively low D2 receptor occupancy at therapeutic doses, so it has a lower risk of extrapyramidal symptoms than haloperidol. - Although extrapyramidal symptoms can occur, dystonia, akathisia, and parkinsonism are less characteristic of quetiapine than of haloperidol. Olanzapine - Olanzapine is an atypical antipsychotic with D2 and 5-HT2A receptor antagonism, and its risk of extrapyramidal symptoms is lower than that of haloperidol. - Although extrapyramidal symptoms can occur, they are less characteristic of olanzapine than of the potent D2 antagonist haloperidol. Clozapine - Clozapine is an atypical antipsychotic with relatively weaker D2 antagonism and potent 5-HT2A blockade, so it has a lower risk of extrapyramidal symptoms. - Although clozapine can cause serious effects such as agranulocytosis and myocarditis, EPS are less common than with typical antipsychotics such as haloperidol.

  6. 6. A woman with acute DVT must continue rifampicin for tuberculosis. Her INR remains subtherapeutic despite monitored warfarin dose escalation, and frequent outpatient INR testing is unavailable. Which anticoagulant should replace warfarin?

    • A. Enoxaparin
    • B. Acenocoumarol
    • C. Rivaroxaban
    • D. Dabigatran
    Show answer

    Answer: A. Enoxaparin

    Enoxaparin provides therapeutic anticoagulation without the rifampicin-related enzyme or transporter interaction and does not require INR monitoring. Acenocoumarol remains susceptible to rifampicin-related induction and requires INR monitoring. Rivaroxaban exposure is reduced by rifampicin induction of CYP3A4 and P-glycoprotein. Dabigatran exposure is reduced by rifampicin induction of P-glycoprotein, so it is also unsuitable during concomitant treatment.

  7. 7. A patient on lithium therapy developed hypertension and was started on a thiazide diuretic. After a few days, he developed coarse tremors and other symptoms suggestive of lithium toxicity. What is the probable mechanism of interaction between thiazide diuretics and lithium?

    • A. Reduced intestinal lithium absorption
    • B. Greater proximal lithium reabsorption
    • C. Increased lithium protein binding
    • D. Inhibited hepatic lithium metabolism
    Show answer

    Answer: B. Greater proximal lithium reabsorption

    Greater proximal lithium reabsorption - Thiazides increase sodium excretion, prompting compensatory proximal tubular sodium reabsorption; lithium is reabsorbed alongside sodium at this site. - Enhanced lithium reabsorption decreases its renal clearance, raising plasma lithium concentrations and causing toxicity such as coarse tremors. Reduced intestinal lithium absorption - Reduced intestinal absorption would lower plasma lithium concentrations rather than cause toxicity. Increased lithium protein binding - Lithium has negligible plasma protein binding, so increased protein binding does not explain the toxicity. Inhibited hepatic lithium metabolism - Lithium is not metabolized and is eliminated unchanged by the kidneys. - Hepatic metabolic inhibition therefore cannot explain the toxicity; thiazides instead increase renal lithium reabsorption.

  8. 8. Which of the following statements about lamotrigine is correct?

    • A. Minimal hepatic metabolism
    • B. First-line therapy for absence seizures
    • C. About one-day elimination half-life
    • D. Reduced efficacy against depressive episodes
    Show answer

    Answer: C. About one-day elimination half-life

    About one-day elimination half-life - Lamotrigine has an adult half-life of approximately 24–33 hours, supporting once- or twice-daily administration. - This relatively long half-life helps maintain stable plasma concentrations and can improve treatment adherence, making the statement correct. Minimal hepatic metabolism - Lamotrigine is significantly metabolized in the liver, mainly by glucuronidation through the UGT1A4 enzyme. - Therefore, this statement is incorrect; hepatic metabolism can contribute to drug interactions with other antiepileptic medicines affecting glucuronidation. Reduced efficacy against depressive episodes - Lamotrigine has important mood-stabilizing properties and is effective in treating or preventing depressive episodes in bipolar disorder. - Thus, decreased efficacy in depression is not characteristic; its benefit in bipolar depression is a clinically distinguishing feature. First-line therapy for absence seizures - Lamotrigine is not generally the first-choice treatment for absence seizures because its efficacy is less established than standard options. - Ethosuximide or valproate are generally preferred initially, while lamotrigine may be limited by slower titration and occasional inadequate efficacy.

  9. 9. Which drug acts on the receptor X shown below in skeletal muscle?

    • A. Dantrolene
    • B. Baclofen
    • C. Vecuronium
    • D. Tubocurarine
    Show answer

    Answer: A. Dantrolene

    Dantrolene - Dantrolene directly inhibits the ryanodine receptor (RyR1) in skeletal-muscle sarcoplasmic reticulum, reducing calcium release. - By limiting intracellular calcium, dantrolene prevents excitation–contraction coupling and is used to treat malignant hyperthermia and central spasticity. Tubocurarine - Tubocurarine acts competitively at postsynaptic nicotinic receptors at the neuromuscular junction, rather than on the intracellular calcium-release channel. - As a non-depolarizing neuromuscular blocker, it prevents acetylcholine binding but does not directly inhibit calcium release from the sarcoplasmic reticulum. Baclofen - Baclofen activates GABA-B receptors in the spinal cord, producing muscle relaxation by reducing excitatory neurotransmitter release. - Its central action reduces spasticity but does not directly target skeletal-muscle ryanodine receptors or sarcoplasmic-reticulum calcium channels. Vecuronium - Vecuronium blocks nicotinic receptors at the neuromuscular junction, preventing neuromuscular transmission during anesthesia. - Although it produces skeletal-muscle relaxation, it acts at the neuromuscular junction rather than directly affecting intracellular calcium release.

  10. 10. Which of the following antidepressant drugs is used in the treatment of nocturnal enuresis?

    • A. Imipramine
    • B. Fluoxetine
    • C. Trazodone
    • D. Sertraline
    Show answer

    Answer: A. Imipramine

    Imipramine - Imipramine, a tricyclic antidepressant, is effective for nocturnal enuresis, particularly in children, and is the characteristic antidepressant associated with this indication. - Its anticholinergic effects may increase bladder capacity, while alpha-adrenergic effects promote internal urethral sphincter contraction. Trazodone - Trazodone is an antidepressant with prominent sedative properties, commonly used for depression and insomnia rather than bladder control. - Although trazodone modulates serotonergic transmission, it lacks an established therapeutic role in nocturnal enuresis and is not the characteristic antidepressant choice. Sertraline - Sertraline is an SSRI primarily used for depression, anxiety disorders, and panic disorder, not for increasing bladder capacity or controlling enuresis. - Unlike imipramine, sertraline lacks the relevant anticholinergic and alpha-adrenergic effects used therapeutically in nocturnal enuresis. Fluoxetine - Fluoxetine is an SSRI primarily used for depression, anxiety disorders, and obsessive-compulsive disorder rather than nocturnal enuresis. - It does not have a primary indication or established efficacy for nocturnal enuresis, unlike the TCA imipramine.

Flashcards: Mood Stabilizers

  1. 1. Which second gen. antipsychotic is associated with gestational diabetes and neonatal seizures?

    Show answer

    Clozapine

  2. 2. Tricyclic antidepressants are associated with the "Tri-C" side effects: _____, _____, _____

    Show answer

    Convulsions · Coma · Cardiotoxicity

  3. 3. is the first FDA-approved oral medication specifically for the treatment of postpartum depression

    Show answer

    Zuranolone

  4. 4. Drug of choice for prophylaxis of mania is:

    Show answer

    Lithium

  5. 5. Which antipsychotic drug class is associated with the development of pigmentary corneal and lens deposits?

    Show answer

    Phenothiazines (specifically Chlorpromazine)

  6. 6. Akathisia secondary to antipsychotic therapy is best managed using which drugs?

    Show answer

    Propranolol

  7. 7. Viloxazine is a recently approved drug for the treatment of

    Show answer

    attention deficit hyperactivity disorder

  8. 8. Typical antipsychotics are associated with anti-cholinergic effects, such as _____ and _____

    Show answer

    dry mouth · constipation

  9. 9. Mirtazapine causes _____ appetite and weight _____

    Show answer

    increased · gain

  10. 10. Neuro/Psych _____ is an atypical antidepressant that can cause _____ in men

    Show answer

    Trazodone · priapism

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF